Medicines and Healthcare Products Regulatory Agency: Clinical Trials

Department of Health and Social Care written question – answered at on 8 March 2023.

Alert me about debates like this

Photo of Graham Brady Graham Brady Chair, Conservative Party 1922 Committee

To ask the Secretary of State for Health and Social Care, what the (a) average and (b) longest time taken by MHRA to evaluate a clinical trial was in each of the last five years for which data is available.

Photo of Will Quince Will Quince Minister of State (Department of Health and Social Care)

For the financial year 2018/19, the average time taken by the Medicines and Healthcare products Regulatory Agency (MHRA) to assess a clinical trial was 23.29 days. The longest time taken was 56 days. For the financial year 2019/20, the average time taken by the MHRA to assess a clinical trial was 23.47 days. The longest time taken was 56 days. For the financial year 2020/21, the average time taken by the MHRA to assess a clinical trial was 21.43 days. The longest time taken was 49 days. For the financial year 2021/22, the average time taken by the MHRA to assess a clinical trial was 27.58 days. The longest time taken was 68 days. For the financial year 2022/23 (April 2022 – February 2023 inclusive), the average time taken by the MHRA to assess a clinical trial was 42.78 days. The longest time taken was 146 days.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.